Isoquercitrin attenuates the osteoclast-mediated bone loss in rheumatoid arthritis via the Nrf2/ROS/NF-κB pathway | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Isoquercitrin attenuates the osteoclast-mediated bone loss in rheumatoid arthritis via the Nrf2/ROS/NF-κB pathway

Authors:: Yan Liu; Tian-qi Li; Jin Bai; Wei-li Liu; Zi-rou Wang; Chong Feng; Ling-ling Pu; Xin-xing Wang; Hui Liu

Reference:: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease; 2024; 1870; 166977

DOI:: 10.1016/j.bbadis.2023.166977

See Abstract

Key Words:: Rheumatoid arthritis; osteoclast; isoquercitrin; RANKL; Nrf2/ROS/NF-κB

Back to index